Evidence map›Paper›PMID 7610051›Full record

ArticleNucleic acids research1995

Ribozyme-mediated RNA degradation in nuclei suspension.

O Heidenreich, S H Kang, D A Brown, X Xu, P Swiderski, J J Rossi, F Eckstein, M Nerenberg

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

O HeidenreichScripps Research Institute, Department of Neuropharmacology, La Jolla, CA 92037, USA.
S H Kang
D A Brown
X Xu
P Swiderski
J J Rossi
F Eckstein
M Nerenberg
Scripps Research Institute · USLoma Linda University · USLoma Linda University Medical Center · USMax Planck Institute of Experimental Medicine · DE

Funding

VPA 985 IN LIVER CIRRHOSIS &ASCITESM01RR000833 · NCRR · SCRIPPS RESEARCH INSTITUTE · PI BABIOR, BERNARD M · 1985 to 2004
$14.0M
VIRAL AND CELLULAR ALTERATIONS DURING INFECTION IN CELL CULTUREP50NS012428 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI OLDSTONE, MICHAEL B · 1985 to 1994
–
MOUSE MODELS FOR HTLV-1 INDUCED PATHOGENESISR01CA050234 · NCI · SCRIPPS RESEARCH INSTITUTE · PI NERENBERG, MICHAEL I · 1990 to 1993
–
NCI NIH HHS CA50234NCRR NIH HHS MO1RR00833NINDS NIH HHS NS12428
6 · The paper itself

Abstract

Ribozymes containing 2'-fluoro- and 2'-amino-modified pyrimidine nucleosides in combination with terminal phosphorothioate linkages were targeted against HTLV-I tax RNA. In order to examine the activity of such chemically modified ribozymes in the nuclear environment, they were incubated with nuclei of a Tax-transformed mouse fibroblast cell line. Ribozyme cleavage of tax RNA was analyzed by the RNase protection assay. Comparison of the cleavage of tax RNA isolated nuclei with that of tax RNA present in nuclei suspension revealed a 30 times more efficient cleavage of the latter one. Pre-treatment with proteinase K and SDS abolished the enhancement of the ribozyme-mediated RNA cleavage. Catalytically inactive ribozymes did not yield any cleavage products. These results demonstrate an augmenting effect of nuclear proteins on the ribozyme-mediated RNA cleavage.

Indexed as

Genes, pXAnimalsBase SequenceCatalysisCell Line, TransformedCell NucleusEndopeptidase KFibroblastsHuman T-lymphotropic virus 1MiceMolecular Sequence DataRNA, CatalyticRNA, ViralSerine EndopeptidasesSodium Dodecyl SulfateStructure-Activity RelationshipEndopeptidase KRNA, CatalyticRNA, ViralSerine EndopeptidasesSodium Dodecyl Sulfate

Identifiers

PMID7610051
PMCPMC307011
OpenAlexW1971193115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.